Promising results of 6 months treatment with insulin detemir in Type 1 diabetic patients

被引：0
|
作者：
Selam, JL
Skeie, S
Vague, P
Bayer, T
Haahr, H
机构：
[1] Hop Hotel Dieu, Paris, France
[2] Hjertelaget Res Fdn, Stavanger, Norway
[3] Timone Hosp, Marseille, France
[4] Novo Nordisk, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
51
引用
收藏
页码：A15 / A15
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of 6-month treatment with insulin detemir in type 1 diabetic patients on a basal/bolus regimen
    Roberts, A
    Bayer, T
    Munksgaard, E
    Lang, H
    Standl, E
    DIABETES, 2001, 50 : A129 - A129
  • [2] Efficacy and safety of 6-month treatment with insulin detemir in type 1 diabetic patients on a basal-bolus regimen
    Roberts, A
    Standl, E
    Bayer, T
    Munksgaard, E
    Lang, H
    DIABETOLOGIA, 2001, 44 : A207 - A207
  • [3] Insulin detemir in the treatment of type 1 and type 2 diabetes
    Philips, Jean-Christophe
    Scheen, Andre
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (03) : 277 - 283
  • [4] Safety and efficacy of insulin detemir treatment in elderly type 2 patients:: 6-month results from PREDICTIVE™
    Dornhorst, Anne
    Virkamaki, Antti
    Hansen, Jes B.
    Hernandez, Francisco
    DIABETES, 2007, 56 : A557 - A557
  • [5] Insulin detemir for the treatment of obese patients with type 2 diabetes
    Hollander, Priscilla A.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 11 - 19
  • [6] A comparison of the basal insulin analog, insulin detemir (NN304), with NPH insulin in the management of type 1 diabetic patients
    Hermansen, K
    Madsbad, S
    Perrild, H
    Kristensen, A
    Axelsen, M
    DIABETES, 2000, 49 : A110 - A111
  • [7] Lower risk of nocturnal hypoglycaemia and favourable weight development in Type 1 diabetic subjects after 12 months treatment with insulin detemir vs. NPH insulin.
    De Leeuw, I
    Vague, P
    Selam, JL
    Skeie, S
    Elte, JWF
    Lang, H
    Draeger, E
    DIABETOLOGIA, 2002, 45 : A257 - A257
  • [8] Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women
    Lapolla, A.
    Di Cianni, G.
    Bruttomesso, D.
    Dalfra, M. G.
    Fresa, R.
    Mello, G.
    Napoli, A.
    Romanelli, T.
    Sciacca, L.
    Stefanelli, G.
    Torlone, E.
    Mannino, D.
    DIABETIC MEDICINE, 2009, 26 (11) : 1182 - 1182
  • [9] Once-daily insulin detemir improves glycemic control and tolerability in patients with type 1 or type 2 diabetes enrolled for 6 months in the PREDICTIVE™ study
    Dornhorst, Anne
    Sreenan, Seamus
    Ackermann, Ralf W.
    Hansen, Jes B.
    DIABETES, 2008, 57 : A583 - A584
  • [10] Lower risk of nocturnal hypoglycaemia and favourable weight development in Type 1 diabetic subjects after 12 months treatment with insulin detemir vs. NPH insulin.
    De Leeuw, I
    Vague, P
    Selam, JL
    Skeie, S
    Elte, JWF
    Lang, H
    Draeger, E
    DIABETOLOGIA, 2002, 45 : A257 - A257
12345